Feedback / Questions
oxaliplatin Pt(IV) prodrug/texaphyrin (OxaliTEX) - OncoTEX
https://www.globenewswire.com/news-release/2022/03/30/2412972/0/en/OncoTEX-Receives-Notice-of-Allowance-for-Patent-in-Korea-Regarding-Ovarian-Cancer-Fighting-Drug-OxaliTEX.html
Mar 30, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next